fashion -WSS

fashion

author：knowledge 2025-09-30 00:46:16 - browse：339

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Teladoc has a new CEO, but challenges remain the same

focus

WSS

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Pharma companies must ensure equitable access to obesity drugs

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

STAT Virtual Event: ASCO Recap, Live!

Eating disorder hotline's move to chatbot carried cost for volunteers

entertainment

fashion

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Coercive sterilizations revealed by STAT prompt outrage

As demand for Covid shots wanes, Moderna seeks its next success

GOP inquiry over gain

Affirmative action in medical school literally saved lives

ADA: All diabetes patients should be screened for liver condition

As demand for Covid shots wanes, Moderna seeks its next success

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Bright Health sells Medicare Advantage business to Molina

Readers discuss the intersection of pregnancy and addiction

leisure time

GOP inquiry over gain

Why do we get seasonal allergies?

My daughter's legacy lives on through her writing, phage therapy

Illumina to lay off 10% of research and development team

The system is set up to fail children with medical complexity

Illumina to lay off 10% of research and development team

hotspot

explore

focus

hotspot